British pharmaceutical company GSK and iTeos Therapeutics announced on Tuesday that they had halted the development of belrestotug, an experimental treatment for lung cancer, after two tests showed that it was ineffective in halting the disease's pro
Johnson & Johnson announced compelling results from the phase 3 QUASAR long-term extension (LTE) study of Tremfya (guselkumab) in adults with moderately to severely active ulcerative colitis (UC). Presented at Digestive Disease Wee...
SCHOTT Pharma, a global leader in drug containment and delivery solutions, has announced a binding agreement with TPG, a prominent alternative asset management firm, under which TPG will acquire a...
IGI, a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ISB 2001.
Biocon Biologics has accomplished a major breakthrough in the U.S. with wide-ranging market access for Yesintek (ustekinumab-kfce), its biosimilar to Stelara, marking its first commercial launch in the country as a fully combined biosimilar company.
A leading contract research and manufacturing organization, Akums Drugs & Pharmaceuticals, has established a patent for its novel extended-release invention of doxylamine and pyridoxine.
An innovation in Space Medicine has been made through the partnership of the Indian Space Research Organisation (ISRO), Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST),and the Department of S...
Eli Lilly’s experimental weight-loss pill, orforglipron, achieved nearly 8% weight loss and notable blood sugar reduction in a late-stage trial for patients with type 2 diabetes. The once-daily oral drug exceeded Wall Street expectations, triggering
.jpg)
In an exclusive interaction with India Pharma Outlook, Chandra Ganjoo, Group CEO of Trivitron Healthcare, discusses how MedTech in India is advancing healthcare through AI-driven diagnostics, local manufacturing, and policy support...
The Authentication Solution Providers’ Association (ASPA) will organize an Open House event on April 24, 2025, at Anantara Downtown Dubai, starting 5:00 PM onwards aimed at protecting consumers, businesses, and economies from the growing threat of
, CDSCO.jpg)